07
Market Access & Health Economics
Navigate payer landscapes and demonstrate therapeutic value
STARTING FROM50,000SAR
LEVELS
Training Levels
Choose the right level for your team
1
Executive Workshop
LEVEL 1TARGET AUDIENCE
Leaders, senior physicians, directors
1 day
KEY TOPICS
- HTA principles, CEA, and CUA
- Payer value proposition & stakeholder drivers
- Pharmacoeconomics modeling (Markov, decision trees, ICER)
- Saudi pathways: NUPCO, MOH formulary, CHI
STARTING FROM
50,000 SAR
OUTCOMES
Learning Outcomes
Define and communicate the clinical and economic value of new therapies
Navigate the Saudi payer landscape for formulary inclusion
Generate Real-World Evidence to support pricing decisions
Analyze budget impact of new interventions
Develop pricing models that balance value and patient access
AVAILABILITY
Training Formats
On-Site Training (KSA)
CERTIFICATE INCLUDED
Virtual Classroom
CERTIFICATE INCLUDED
Europe Immersion
CERTIFICATE INCLUDED
All participants receive an MFG Training certified completion certificate upon successful program completion.
Key Topics
Key Topics
- 1Health Technology Assessment (HTA) & Cost-Effectiveness Analysis
- 2Identifying Stakeholders & Tailoring Payer Value Dossiers
- 3Pharmacoeconomic Modeling Techniques & ICER Interpretation
- 4Global vs. Local Market Access Trends (NUPCO, MOH, CHI)
Not Sure Where to Start?
Assess your team's experience levels and exact training needs with a customized consultation.
- Level Recommendations
- Customized Proposals
- Flexible Scheduling